ConductScience.org, home

Paper7985998

Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus.

Schaad HJ and 4 others. Antimicrob Agents Chemother, 1994. Cited by 45 papers, by iCite.

Cite this record

ConductScience Library. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus. Papers, record 7985998. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7985998

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1994
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
45
iCite
Relative citation ratio, by iCite
1.97
iCite
Revised in PubMed
2021-05-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schaad HJH J
2Chuard CC
3Vaudaux PP
4Waldvogel FAF A
5Lew DPD P

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug Therapy, CombinationMajor topic
Foreign-Body ReactionMajor topic
RifampinMajor topic
Staphylococcal InfectionsMajor topic
TeicoplaninMajor topic
VancomycinMajor topic
Animals
Drug Resistance, Microbial
Methicillin Resistance
Microbial Sensitivity Tests
Rats
Rats, Wistar
Staphylococcus aureus

Source PubMed

Download CSV of topics

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12143434Resistance to vancomycin and teicoplanin: an emerging clinical problem.Clin Microbiol Rev1990https://conductscience.org/library/papers/2143434PubMed
22965135Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.J Antimicrob Chemother1988https://conductscience.org/library/papers/2965135PubMed
32149812Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2149812PubMed
41963526Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/1963526PubMed
51826594Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1826594PubMed
62128441Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2128441PubMed
72150908Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2150908PubMed
81903801Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials.J Infect Dis1991https://conductscience.org/library/papers/1903801PubMed
91828134Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1828134PubMed
101829076Teicoplanin monotherapy of serious infections caused by gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trial.J Antimicrob Chemother1991https://conductscience.org/library/papers/1829076PubMed
111829079A review of the safety profile of teicoplanin.J Antimicrob Chemother1991https://conductscience.org/library/papers/1829079PubMed
121929035Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis.Ann Intern Med1991https://conductscience.org/library/papers/1929035PubMed
13249793Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.JAMA1978https://conductscience.org/library/papers/249793PubMed
147119479Pathogenesis of foreign body infection: description and characteristics of an animal model.J Infect Dis1982https://conductscience.org/library/papers/7119479PubMed
156827150Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin.J Infect Dis1983https://conductscience.org/library/papers/6827150PubMed
166356280Clinical study of combination therapy with oxacillin and rifampin for staphylococcal infections.Rev Infect Dis1983https://conductscience.org/library/papers/6356280PubMed
176236747Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6236747PubMed
186237606In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6237606PubMed
196239854Teicoplanin.J Antimicrob Chemother1984https://conductscience.org/library/papers/6239854PubMed
203965588Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.J Infect Dis1985https://conductscience.org/library/papers/3965588PubMed

See all 50 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.

PMIDTitleJournalYearIn PapersSource
36447581Rifaximine spacer application is not superior to local teicoplanin treatment in a rat model of osteomyelitis.North Clin Istanb2022https://conductscience.org/library/papers/36447581PubMed
22833247Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureus.Eur J Clin Microbiol Infect Dis2012https://conductscience.org/library/papers/22833247PubMed
21189340Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21189340PubMed
19364855Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19364855PubMed
18724774The guinea pig as a model of infectious diseases.Comp Med2008https://conductscience.org/library/papers/18724774PubMed
16608512Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection.BMC Infect Dis2006https://conductscience.org/library/papers/16608512PubMed
16127054Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother2005https://conductscience.org/library/papers/16127054PubMed
15631541Infections associated with medical devices: pathogenesis, management and prophylaxis.Drugs2005https://conductscience.org/library/papers/15631541PubMed
15273106Modulation of fibronectin adhesins and other virulence factors in a teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/15273106PubMed
11959588Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/11959588PubMed
9303384Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9303384PubMed
7486895Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7486895PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7985998

GET https://conductscience.org/api/papers/v1/7985998/references?page=2